Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...

Medically reviewed by Brian Bezack, DO Inhaler colors, such as blue, often are used to identify a specific type of inhaler ...

In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...

GSK, leading the COPD market with its Trelegy ... therapies should not overshadow choosing the best therapy for each patient. "Are dry powder inhalers the key to sustainable respiratory care?" ...

Available treatments for COPD are mainly palliative ... destruction of the airways associated with the disease 7. Inhaled corticosteroids (ICS), short- and long-acting β 2-agonists (SABA and ...

Use inhalers: There is not a one size fits all inhaler approach for COPD. Two types of inhalers COPD patients might use: Tan says some people may just use a bronchodilator, but people with more ...

Teva has launched new digital inhaler and drug combination in the US, containing built-in sensors that connect to a phone to help manage asthma and COPD symptoms. Israel-based Teva said the ...